 |
|
|
| |
9th Conference on Retroviruses and Opportunistic Infections
Seattle, Washington, February, 2002 |
| |
| |
- Genotypic Mutations to Predict Kaletra Viral Response - April 11, 2002
- Impact of Hepatitis Coinfection on Health & Survival - April 11, 2002
- Summary Highlights of Retrovirus 2002 - April 4, 2002
- Bone Density and HIV Infection David Alain Wohl, MD
University of North Carolina AIDS Treatment and Research Unit - April 3, 2002
- Rosiglitazone In The Treatment of HAART-Associated Lipodystrophy: a randomized, double-blinded, placebo controlled study Written by Jules Levin - March 28, 2002
- Highlights of Treatment for HBV or HCV Coinfection Written for NATAP by Raymond Chung, MD, Director of Liver Transplantation Program, Massachusetts General Hospital - March 22, 2002
- HIV Resistance Andrew Zolopa, MD, Stanford University - March 22, 2002
- Women with HIV: More conference time Written for NATAP by Judith Aberg, Washington University, St Louis - March 20, 2002
- Insulin Resistance, Glucose Intolerance: What does it all mean? Written for NATAP by Judith Aberg, Washington University, St Louis - March 20, 2002
- Complications of HIV; HIV+ Not in Care or Being Tested - March 19, 2002
- Maternal - Fetal Transmission at Retrovirus Written by Danielle Milano, MD, Boriken Family Health Services, New York - March 18, 2002
- HCV Viral Kinetics Written by Nancy Shulman, MD, Stanford University, and Jules Levin - March 18, 2002
- HIV and Women at Retrovirus Written for NATAP by Danielle Milano, MD, Boriken Family Health Services, NYC - March 18, 2002
- Tenofovir Resistance and its Role in Therapy - March 14, 2002
- Hepatitis B and C Coinfection Report - Wriiten by Nancy Shulman, MD, Stanford University - March 14, 2002
- T-20 and Beyond: Inhibition of HIV Attachment and Fusion at the 9th CROI - Reported by Christopher D. Pilcher, M.D. UNC at Chapel Hill Center for AIDS Research - March 11, 2002
- PRIMARY HIV INFECTION-THE 'WINDOW OF OPPORTUNITY' - Reported by Christopher D. Pilcher, MD of the University of North Carolina at Chapel Hill Center for AIDS Research - March 11, 2002
- Opportunistic Conditions in the HAART Era - David Alain Wohl, MD University of North Carolina AIDS treatment and Research Center - March 11, 2002
- HIV and Cardiovascular Disease: True True or Unrelated? The Debate Continues - Reported by Judith Aberg, MD, Medical Director, HIV Services, washington University School of Medicine, St. Louis, and ACTG researcher - March 11, 2002
- Structured Treatment Interruptions - Reported by Mike Youle, MD, Royal Free HIV Clinic, London, UK - March 11, 2002
- Hepatitis B Report : More Acute HBV Infection in HIV-Patients; 3TC Protective; 14% Vaccinated - March 11, 2002
- Tipranavir (new PI) Resistance Report - March 11, 2002
- When To Begin Therapy: deferring therapy may reduce health and longevity - March 11, 2002
- Pharmacogentics - March 6, 2002
- Adherence to HIV Therapy - Helping the Medicine Go Down David Alain Wohl, MD - University of North Carolina AIDS Clinical Treatment and Research Center - March 6, 2002
- Immunology Written by David Margolis, MD, University of Texas, Southwestern Medical Center, and ACTG researcher - March 6, 2002
- Do Older Folks (>50) Progress More Quickly - March 3, 2002
- Attacking Lipodystrophy
David Alain Wohl, MD - University of North Carolina AIDS Treatment and Research Center - March 3, 2002
- Switching Antiretroviral Therapy for Lipoatrophy
David Alain Wohl, MD - University of North Carolina AIDS Treatment and Research Center - March 3, 2002
- IL-2 & HCV/HIV Coinfection - March 3, 2002
- Atazanavir+saquinavir once daily vs RTV/SQV twice daily - March 3, 2002
- New drugs: perhaps some genuine excitement this time
Reported on the Retrovirus conference for NATAP by Graham Moyle, MD, M. B. B. S., Chelsea & Westminster Hospital, London, UK - March 3, 2002
- Risk of Death & Grade 4 events in HCV/HIV Coinfected - March 3, 2002
- Direct Observed Therapy In Methadone and Cocaine Users - March 3, 2002
- Switching from a Protease Inhibitor to Efavirenz, Nevirapine or Abacavir - March 3, 2002
- Hepatitis C Report from the Retrovirus Conference: report 1 - March 1, 2002
- 9th Retrovirus Conference Highlights From Late Breakers - March 1, 2002
- Kaletra Once A Day - Feb 27, 2002
- 9th Retrovirus Conference: lipodystrophy, complications, OIs, switching regimens - Feb 25, 2002
- SCHERING-PLOUGH PRESENTS CLINICAL DATA ON CCR5 RECEPTOR ANTAGONIST AT 9TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS - Feb 25, 2002
- New Drugs Reported at 9th Retrovirus Conference - Feb 25, 2002
- Where Did AIDS Come From: Opening Session at Retroviruses Conference - Feb 24, 2002
|
|
| |
|
|
|
|
|
